Blake Aftab
CIK 1886986 · Chief Scientific Officer · last filed 2026-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.0K
Companies
1
Total Filings
21
Lifetime Open-Market Net
-$564.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | Chief Scientific Officer | 2,981 | $8.05 | $24.0K | -$564.0K | 21 | 2026-03-27 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-21 | ACET | Sell (S) | −8,067 | -$131.3K | EDGAR |
| 2022-10-14 | ACET | Mixed | −6,191 | -$126.6K | EDGAR |
| 2022-08-08 | ACET | Mixed | +10,467 | -$101.0K | EDGAR |
| 2022-08-05 | ACET | Sell (S) | −6,968 | -$125.4K | EDGAR |
| 2022-08-03 | ACET | Sell (S) | −6,968 | -$115.9K | EDGAR |
| 2022-07-07 | ACET | Sell (S) | −1,363 | -$19.8K | EDGAR |
| 2022-05-12 | ACET | Grant (A) | — | $0 | EDGAR |
| 2022-02-16 | ACET | Mixed | +10,467 | -$79.0K | EDGAR |
| 2022-02-01 | ACET | Mixed | +10,436 | -$65.0K | EDGAR |
| 2022-01-11 | ACET | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.